T1	Participants 53 100	prevention of radiocontrast-induced nephropathy
T2	Participants 133 216	protecting contrast-induced nephropathy in patients undergoing coronary procedures.
T3	Participants 335 370	contrast-induced nephropathy (CIN).
T4	Participants 656 764	264 patients who were scheduled for cardiovascular procedures and had a baseline creatinine level >1.2 mg/dL
